Community/Retail

Patients with chronic obstructive pulmonary disease (COPD) who receive a flu vaccine are significantly less likely to be hospitalized with influenza.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, has announced the ninth annual Directions in Pharmacy® continuing education conference series, which will take place in 4 major cities across the United States in spring 2019.

To reduce the likelihood of people giving up on PrEP because of difficulty committing to multiple annual visits, a team of investigators created PrEP@Home, a home-based monitoring system that will allow people on the PrEP regimen to meet with their health care providers just once a year, its creators say.

A recent study analyzed how health systems utilize and integrate virtual care into their daily practice.

Under the rule, prescription rebates may be passed directly to patients at the pharmacy counter, effectively creating a new safe harbor designed for price reductions at the point of sale.

The disproportionate impact on the US African-American population is highlighted each year on February 7, National Black HIV/AIDS Awareness Day.

Officials with the FDA have approved caplacizumab-yhdp (Cablivi, Sanofi) injection for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening blood clotting autoimmune disorder.

The 2010 remanufacturing of Purdue Pharma's OxyContin (oxycodone) into an "abuse-deterrent formulation" has been identified as a key contributing factor in opioid abusers switching to heroin injections and the corresponding surge in hepatitis C virus (HCV) infections, according to a new Rand Corporation study.

Along with providing screenings every Thursday in February, including Valentine’s Day, at MinuteClinlic locations nationwide, CVS has also extended its support to American Heart Association’s Go Red for Women with new $15 million commitment.

Real pharmacists speak out about the alleged fake Walgreens pharmacist.

A New Drug Application (NDA) and a supplemental NDA (sNDA) were accepted for the Priority Review for products being developed by Merck.

Several states have passed laws restricting initial opioid prescribing as a method to address the opioid epidemic.

Dr. Reddy’s Laboratories is continuing its voluntary nationwide recall of the antiepileptic drug Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) in single-dose infusion bags to the hospital level in the United States.

The global hepatitis C virus epidemic faces several barriers and meeting WHO target goals will be difficult unless a vast strategy is implemented.

Zoster vaccine recombinant, adjuvanted (Shingrix, GlaxoSmithKline) was approved in October 2017 for the prevention of the viral infection in adults 50 and older.

At least 79 individual cases of measles in the United States have been reported since the start of 2019.

Why is this customer unable to walk?

If you have a burning desire to provide more and better health information to patients, consider this: there is a reason you went to pharmacy school, and there is a reason that you still have that passion.

The FDA is warning patients and doctors that certain test strips used to monitor levels of the blood thinner warfarin may provide inaccurate results and should not be relied upon to adjust the drug dosage.

We talk to 5 pharmacists about their short-term and long-term goals

This is the seventh part of a series on how pharmacy professionals have been depicted on TV, both in a positive and a negative manner.

Officials with the FDA have expanded the label of pemetrexed for injection (Alimta, Eli Lilly) in combination with pembrolizumab (Keytruda, Merck) and platinum chemotherapy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

There are multiple treatment options for an overactive bladder.

The 'polar vortex' that gripped much of the country this week has not stopped pharmacists from helping patients.

Andrea Cusack, RPh, has made national headlines braving treacherous conditions delivering prescriptions in a very creative way.

With new products coming to the pharmacy market, such as smart devices and digital medicines, the profession will need to develop quickly to keep up pace.